Literature DB >> 31662565

I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.

Julia V Malamitsi1, John T Koutsikos2, Stamatia I Giourgouli3, Sophia F Zachaki4, Theodoros A Pipikos5, Fani J Vlachou5, Vassilios K Prassopoulos5.   

Abstract

BACKGROUND/AIM: The aim of the study was to prospectively compare I-131 postablation Whole Body scan (WBS) and Single Photon Emission Computerized Tomography/Computerized Tomography (SPECT/CT) scan on thyroid cancer patients. PATIENTS AND METHODS: Overall, 58 patients with papillary thyroid carcinoma were submitted to total thyroidectomy and I-131 remnant ablation. Post-ablation WBS and SPECT/CT scans performed on the same day were compared. Results of SPECT/CT were confirmed by neck and upper mediastinum ultrasound scan and on specific cases by a fully diagnostic CT scan, other tests and definitive histology acting as the gold standard. A total of 36/58 patients were followed-up for 5 years to detect relapse.
RESULTS: Mac Nemar Chi square and Fisher's exact tests disclosed statistically significant differences between WBS and SPECT/CT scan, concerning cervical lymphadenopathy detection (p=0.031) and relapse prediction by NM stage (p=0.033), respectively; SPECT/CT was more accurate in both comparisons.
CONCLUSION: In papillary thyroid carcinoma I-131 post-ablation SPECT/CT scan detects cervical lymphadenopathy and predicts relapse by NM stage more accurately than WBS. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  I-131 postablation scan; Papillary thyroid carcinoma; SPECT/CT; whole body scan

Mesh:

Substances:

Year:  2019        PMID: 31662565      PMCID: PMC6899111          DOI: 10.21873/invivo.11731

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  30 in total

1.  Regional lymph node involvement in T1 papillary thyroid carcinoma: a bicentric prospective SPECT/CT study.

Authors:  Mona Mustafa; Torsten Kuwert; Kathrin Weber; Peter Knesewitsch; Thomas Negele; Alexander Haug; Rainer Linke; Peter Bartenstein; Daniela Schmidt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-01       Impact factor: 9.236

Review 2.  Pictorial Review of False-Positive Results on Radioiodine Scintigrams of Patients with Differentiated Thyroid Cancer.

Authors:  Amy V Chudgar; Jagruti C Shah
Journal:  Radiographics       Date:  2017 Jan-Feb       Impact factor: 5.333

3.  Postablation (131)I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer.

Authors:  Renaud Ciappuccini; Natacha Heutte; Géraldine Trzepla; Jean-Pierre Rame; Dominique Vaur; Nicolas Aide; Stéphane Bardet
Journal:  Eur J Endocrinol       Date:  2011-04-06       Impact factor: 6.664

4.  Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.

Authors:  Yuka Yamamoto; Yoshihiro Nishiyama; Toshihide Monden; Yoshitaka Matsumura; Katashi Satoh; Motoomi Ohkawa
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

5.  Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.

Authors:  F Pacini; E Molinaro; M G Castagna; L Agate; R Elisei; C Ceccarelli; F Lippi; D Taddei; L Grasso; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

6.  Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.

Authors:  Nicolas Aide; Natacha Heutte; Jean-Pierre Rame; Elise Rousseau; Cédric Loiseau; Michel Henry-Amar; Stéphane Bardet
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

7.  Post I-131 therapy scanning in patients with thyroid carcinoma metastases: an unnecessary cost or a relevant contribution?

Authors:  Pedro Wesley Souza Rosário; Alvaro Luís Barroso; Leonardo Lamego Rezende; Eduardo Lanza Padrão; Tales Alvarenga Fagundes; Gustavo Cancela Penna; Saulo Purisch
Journal:  Clin Nucl Med       Date:  2004-12       Impact factor: 7.794

8.  Radioiodine sinus uptake related to mucosal thickening or aspergilloma: a case series of an unrecognized event well evidenced by SPECT/CT.

Authors:  Renaud Ciappuccini; David Blanchard; Jean-Pierre Rame; Dominique de Raucourt; Emmanuel Babin; Stéphane Bardet
Journal:  Cancer Imaging       Date:  2017-01-13       Impact factor: 3.909

9.  Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.

Authors:  Chang-Hee Lee; Ji-Hoon Jung; Seung Hyun Son; Chae Moon Hong; Ju Hye Jeong; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

10.  Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma

Authors:  Aylin Oral; Bülent Yazıcı; Cenk Eraslan; Zeynep Burak
Journal:  Mol Imaging Radionucl Ther       Date:  2018-10-09
View more
  1 in total

1.  Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer.

Authors:  Sara Ahmadi; Alexandra Coleman; Nathalie Silva de Morais; Iñigo Landa; Theodora Pappa; Alex Kang; Matthew I Kim; Ellen Marqusee; Erik K Alexander
Journal:  Endocr Connect       Date:  2022-05-25       Impact factor: 3.221

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.